Overview
Thaminda Ramanayake holds the position of Venture Partner @ Entree Bio at Entrée Capital [1][4]. Ramanayake is described as a dealmaker, negotiator, life-science strategist and builder of high-performing teams, with distinctive expertise as both a published scientist and executor of complex transactions [2]. Ramanayake's educational background includes a Master of Science in Immunology from the University of Rochester School of Medicine and Dentistry [13], an MBA in Finance from the University of Rochester Simon Business School [11], and completion of a Negotiations Strategy Workshop at The Wharton School [12]. Current roles include Chief Executive Officer of ANAVEON AG [3], Managing Director at Origin Advisors, LLC [6], Board Member at Mana.bio [5], and Strategic Advisor to CatAIlyst Inc. [7]. Previous positions include Chief Business & Strategy Officer at CureVac [9] and Chief Business Officer at Affini-T Therapeutics [10].
Profile introduction
Dealmaker, negotiator, life-science strategist and builder of high-performing teams. Uniquely skilled as a published scientist and executor of complex transactions.
Career history
- Chief Executive OfficerFeb 2026 to presentANAVEON AG
- Venture Partner @ Entree BioOct 2025 to presentEntrée Capital
- Board MemberApr 2026 to presentMana.bio
- Managing DirectorJan 2026 to presentOrigin Advisors, LLC
- Strategic Advisor2020 to presentCatAIlyst Inc.
- Board MemberOct 2024 to Jan 2026Alliance for mRNA Medicines
- Chief Business & Strategy OfficerJun 2024 to Dec 2025CureVac
- Chief Business OfficerJun 2023 to May 2024Affini-T Therapeutics
Education
MBA, Finance2009 - 2010University of RochesterSimon Business School
Negotiations Strategy Workshop2016 - 2016The Wharton School
- MS, Immunology2004 - 2007University of Rochester School of Medicine and Dentistry
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.